133 / 400
MONDAY
TUESDAY
WEDNESDAY
THURSDAY
German language Session
Q&A Modul
SCIENTIFIC PROGRAMME
125
› Tuesday, 10 October 2017
ST-10 (d)
State-of-the-Art-Symposium
08:15–09:45
|
Hall A2
TOPIC 10:
Gerontopsychiatry
Gerontopsychiatrie: Depression und Delir
Chairs:
Vjera Holthoff-Detto, Germany
Michael Hüll, Germany
001
Komplexe Behandlungsstrategien der Altersde-
pression
Vjera Holthoff-Detto, Germany
002
Delire bei älteren Menschen: vermeiden, erken-
nen, behandeln
Michael Hüll, Germany
S-119
Symposium
08:15–09:45
|
Hall A3
TOPIC 4:
Affective disorders
Beyond classical antidepressants: experimental
psychopharmacological interventions to treat social
and affective disorders
Chairs:
Malek Bajbouj, Germany
Erich Seifritz, Switzerland
001
Psilocybin in the treatment of affective disorders
Franz Vollenweider, Switzerland
002
Ketamin in the treatment of affective disorders
Simone Grimm, Germany
003
Augmentation of psychotherapy with DMT,
ayahuasca, psilocybin and ketamin
Milan Scheidegger, Switzerland
004
Oxytocin in the treatment of disturbed social
interaction
Markus Heinrichs, Germany
S-120
Symposium
08:15–09:45
|
Hall A5
TOPIC 14:
Neurobiology and genetics
The search for functional targets in the post-genom-
ics era of schizophrenia
Chairs:
Dan Rujescu, Germany
Andreas Meyer-Lindenberg, Germany
001
Genomics of schizophrenia: where do we stand?
Dan Rujescu, Germany
002
Translational imaging evidence for function-
ality and mechanisms of GWA-identified genetic
variants
Andreas Meyer-Lindenberg, Germany
003
Epigenetic processes in neuropsychiatry disorders
Moshe Szyf, Canada
S-121
Symposium
08:15–09:45
|
Hall A1
TOPIC 3:
Psychotic disorders
Symptom dimensions in schizophrenia – brain
correlates and personalised treatment options
Chairs:
Tilo Kircher, Germany
Werner Strik, Switzerland
001
A three dimensional symptom structure of
schizophrenia is linked to specific structural and
functional brain changes
Werner Strik, Switzerland
002
The neurobiology of formal thought disorder:
specific for schizophrenia?
Tilo Kircher, Germany
003
Speech graphs and brain graphs: can we
improve outcomes of schizophrenia by targeting
language?
Lena K. Palaniyappan, United Kingdom
004
Language pathways in the brain and their basis
for the symptoms of schizophrenia
Philipp Homan, USA